Prevalence of PIPc by indicators of omission of appropriate dispensing
| Indicator | No of children who were not prescribed appropriate medication | No of children eligible to be prescribed appropriate medication | Children who were not prescribed appropriate prescription (%) | 95% CI |
| A spacer device should be prescribed at least every 12 months to children under 12 years of age who are prescribed a pressurised metered-dose inhaler | 39 945 | 57 010 | 70.1 | 69.4 to 70.8 |
| An emollient should be prescribed to children prescribed greater than one topical corticosteroid in a year | 7479 | 13 953 | 53.6 | 52.4 to 54.8 |
| An inhaled corticosteroid should be prescribed to children aged 5–15 years who are prescribed a long-acting beta-2 agonist | 18 | 45 | 40.0 | 21.5 to 58.7 |
| An inhaled short-acting beta-2 agonist should be prescribed to children under 5 years of age who are prescribed a leukotriene receptor antagonist | 1914 | 5146 | 37.2 | 35.5 to 38.9 |
| An inhaled short-acting beta-2 agonist should be prescribed to all children who are prescribed two or more inhaled corticosteroids | 1410 | 22 492 | 6.3 | 5.9 to 6.5 |